Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
19822 | 488 | 44.1 | 93% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
328 | 3 | PHOSPHOLIPASE D//STIM1//REGUCALCIN | 38118 |
1486 | 2 | PROTEIN KINASE C//BRYOSTATIN//BRYOSTATIN 1 | 7631 |
19822 | 1 | PAR 4//ATYPICAL PROTEIN KINASE C//PROTEIN KINASE C IOTA | 488 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PAR 4 | authKW | 2566595 | 13% | 63% | 65 |
2 | ATYPICAL PROTEIN KINASE C | authKW | 1143947 | 6% | 63% | 29 |
3 | PROTEIN KINASE C IOTA | authKW | 362014 | 2% | 64% | 9 |
4 | PROSTATE APOPTOSIS RESPONSE 4 | authKW | 333709 | 2% | 67% | 8 |
5 | PKC IOTA | authKW | 298126 | 2% | 53% | 9 |
6 | LP MARKEY CANC | address | 250278 | 2% | 50% | 8 |
7 | ATYPICAL PKCS | authKW | 223466 | 1% | 71% | 5 |
8 | P62 | authKW | 208399 | 7% | 9% | 36 |
9 | PROGRAM CELLULAR MOL BIOSCI | address | 200219 | 2% | 40% | 8 |
10 | PB1 DOMAIN | authKW | 150164 | 1% | 40% | 6 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Cell Biology | 1700 | 31% | 0% | 151 |
2 | Biochemistry & Molecular Biology | 1179 | 42% | 0% | 205 |
3 | Oncology | 1068 | 25% | 0% | 124 |
4 | Endocrinology & Metabolism | 173 | 8% | 0% | 41 |
5 | Genetics & Heredity | 52 | 6% | 0% | 28 |
6 | Medicine, Research & Experimental | 49 | 5% | 0% | 24 |
7 | Biophysics | 38 | 4% | 0% | 21 |
8 | Neurosciences | 26 | 7% | 0% | 34 |
9 | Pathology | 23 | 3% | 0% | 13 |
10 | Chemistry, Medicinal | 4 | 2% | 0% | 8 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | LP MARKEY CANC | 250278 | 2% | 50% | 8 |
2 | PROGRAM CELLULAR MOL BIOSCI | 200219 | 2% | 40% | 8 |
3 | GLAXO WELLCOME CSIC BIOL MOL CELULAR | 125143 | 0% | 100% | 2 |
4 | GRP CELLULAR SIGNALING | 125143 | 0% | 100% | 2 |
5 | ALLERGY PULM CRIT CARE MED MEDTHORAC | 62571 | 0% | 100% | 1 |
6 | BILIARY PANCREAT SURGCANC | 62571 | 0% | 100% | 1 |
7 | BIO5OV | 62571 | 0% | 100% | 1 |
8 | DKFZ JR GRP BRAIN TUMOR TRANSLAT TARGETS | 62571 | 0% | 100% | 1 |
9 | DPT G DELSOL | 62571 | 0% | 100% | 1 |
10 | GENE EXP S MODERN DIAGNOST THER METHODS | 62571 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ADVANCES IN ENZYME REGULATION | 939 | 1% | 1% | 3 |
2 | ONCOGENE | 758 | 3% | 0% | 15 |
3 | EXPERT OPINION ON THERAPEUTIC TARGETS | 722 | 1% | 0% | 4 |
4 | EMBO REPORTS | 715 | 1% | 0% | 5 |
5 | MOLECULAR AND CELLULAR BIOLOGY | 696 | 3% | 0% | 16 |
6 | JOURNAL OF BIOLOGICAL CHEMISTRY | 643 | 8% | 0% | 41 |
7 | CANCER BIOLOGY & THERAPY | 549 | 1% | 0% | 5 |
8 | EMBO JOURNAL | 508 | 2% | 0% | 12 |
9 | CANCER RESEARCH | 493 | 4% | 0% | 18 |
10 | PEZCOLLER FOUNDATION SYMPOSIA | 489 | 1% | 0% | 4 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PAR 4 | 2566595 | 13% | 63% | 65 | Search PAR+4 | Search PAR+4 |
2 | ATYPICAL PROTEIN KINASE C | 1143947 | 6% | 63% | 29 | Search ATYPICAL+PROTEIN+KINASE+C | Search ATYPICAL+PROTEIN+KINASE+C |
3 | PROTEIN KINASE C IOTA | 362014 | 2% | 64% | 9 | Search PROTEIN+KINASE+C+IOTA | Search PROTEIN+KINASE+C+IOTA |
4 | PROSTATE APOPTOSIS RESPONSE 4 | 333709 | 2% | 67% | 8 | Search PROSTATE+APOPTOSIS+RESPONSE+4 | Search PROSTATE+APOPTOSIS+RESPONSE+4 |
5 | PKC IOTA | 298126 | 2% | 53% | 9 | Search PKC+IOTA | Search PKC+IOTA |
6 | ATYPICAL PKCS | 223466 | 1% | 71% | 5 | Search ATYPICAL+PKCS | Search ATYPICAL+PKCS |
7 | P62 | 208399 | 7% | 9% | 36 | Search P62 | Search P62 |
8 | PB1 DOMAIN | 150164 | 1% | 40% | 6 | Search PB1+DOMAIN | Search PB1+DOMAIN |
9 | PKC ZETA | 144281 | 3% | 14% | 16 | Search PKC+ZETA | Search PKC+ZETA |
10 | AUROTHIOMALATE | 129168 | 2% | 26% | 8 | Search AUROTHIOMALATE | Search AUROTHIOMALATE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | RASOOL, RU , NAYAK, D , CHAKRABORTY, S , KATOCH, A , FAHEEM, MM , AMIN, H , GOSWAMI, A , (2016) A JOURNEY BEYOND APOPTOSIS: NEW ENIGMA OF CONTROLLING METASTASIS BY PRO-APOPTOTIC PAR-4.CLINICAL & EXPERIMENTAL METASTASIS. VOL. 33. ISSUE 8. P. 757 -764 | 46 | 81% | 0 |
2 | IRBY, RB , KLINE, CLB , (2013) PAR-4 AS A POTENTIAL TARGET FOR CANCER THERAPY.EXPERT OPINION ON THERAPEUTIC TARGETS. VOL. 17. ISSUE 1. P. 77-87 | 50 | 58% | 7 |
3 | SATHERLEY, LK , SUN, PH , JI, K , MASON, M , HARGEST, R , JIANG, WG , YE, L , (2016) PROSTATE APOPTOSIS RESPONSE-4 (PAR4) SUPPRESSES GROWTH AND INVASION OF BREAST CANCER CELLS AND IS POSITIVELY ASSOCIATED WITH PATIENT SURVIVAL.ANTICANCER RESEARCH. VOL. 36. ISSUE 3. P. 1227 -1235 | 24 | 89% | 0 |
4 | FIELDS, AP , LINCH, M , RIOU, P , JUSTILIEN, V , PARKER, PJ , (2014) ATYPICAL PROTEIN KINASE C IOTA AS A HUMAN ONCOGENE AND THERAPEUTIC TARGET.BIOCHEMICAL PHARMACOLOGY. VOL. 88. ISSUE 1. P. 1 -11 | 41 | 45% | 19 |
5 | LIU, YX , GILBERT, MR , KYPRIANOU, N , RANGNEKAR, VM , HORBINSKI, C , (2014) THE TUMOR SUPPRESSOR PROSTATE APOPTOSIS RESPONSE-4 (PAR-4) IS REGULATED BY MUTANT IDH1 AND KILLS GLIOMA STEM CELLS.ACTA NEUROPATHOLOGICA. VOL. 128. ISSUE 5. P. 723 -732 | 34 | 62% | 1 |
6 | HEBBAR, N , SHRESTHA-BHATTARAI, T , RANGNEKAR, VM , (2014) CANCER-SELECTIVE APOPTOSIS BY TUMOR SUPPRESSOR PAR-4.ANTICANCER GENES. VOL. 818. ISSUE . P. 155 -166 | 26 | 76% | 1 |
7 | PEREIRA, MC , DE BESSA-GARCIA, SA , BURIKHANOV, R , PAVANELLI, AC , ANTUNES, L , RANGNEKAR, VM , NAGAI, MA , (2013) PROSTATE APOPTOSIS RESPONSE-4 IS INVOLVED IN THE APOPTOSIS RESPONSE TO DOCETAXEL IN MCF-7 BREAST CANCER CELLS.INTERNATIONAL JOURNAL OF ONCOLOGY. VOL. 43. ISSUE 2. P. 531-538 | 27 | 63% | 6 |
8 | MURRAY, NR , KALARI, KR , FIELDS, AP , (2011) PROTEIN KINASE C IOTA EXPRESSION AND ONCOGENIC SIGNALING MECHANISMS IN CANCER.JOURNAL OF CELLULAR PHYSIOLOGY. VOL. 226. ISSUE 4. P. 879 -887 | 37 | 41% | 40 |
9 | SHRESTHA-BHATTARAI, T , RANGNEKAR, VM , (2010) CANCER-SELECTIVE APOPTOTIC EFFECTS OF EXTRACELLULAR AND INTRACELLULAR PAR-4.ONCOGENE. VOL. 29. ISSUE 27. P. 3873 -3880 | 27 | 59% | 37 |
10 | ROFFEY, JRA , OTT, GR , (2014) MODULATORS OF ATYPICAL PROTEIN KINASE C AS ANTICANCER AGENTS.ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 49. VOL. 49. ISSUE . P. 189 -206 | 38 | 42% | 0 |
Classes with closest relation at Level 1 |